Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lionel H Opie

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics|May 15, 2003
Tedisamil in coronary disease: additional benefits in the therapy of atrial fibrillation?Lionel H Opie
Journal of Hypertension|January 15, 2008
Beta-blockade should not be among several choices for initial therapy of hypertensionLionel H Opie
Lancet (London, England)|August 1, 2006
Donepezil for severe Alzheimer's diseaseLionel H Opie
Circulation|January 24, 2007
Metabolic syndromeLionel H Opie
The New England Journal of Medicine|August 16, 2013
Mediterranean diet for primary prevention of cardiovascular diseaseLionel H Opie
Lancet (London, England)|August 27, 2013
Recording of smoking history in death notificationLionel H Opie
Journal of the American College of Cardiology|March 7, 2009
Caloric restriction models reverse metabolic syndromeLionel H Opie
Cardiovascular Journal of Africa|September 6, 2014
Cognitive decline: mechanisms and proposed role of the renin-angiotensin-aldosterone systemLionel H Opie
Journal of the American College of Cardiology|December 3, 2014
Early intravenous beta-blockade before primary percutaneous coronary intervention gives major benefits, apparently without side effectsLionel H Opie
Experimental Physiology|July 27, 2012
Cardioprotection at a distance - remote conditioning takes the stageLionel H Opie
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Journal of Cardiovascular Pharmacology and Therapeutics|May 15, 2003
Tedisamil in coronary disease: additional benefits in the therapy of atrial fibrillation?Lionel H Opie
Journal of Hypertension|January 15, 2008
Beta-blockade should not be among several choices for initial therapy of hypertensionLionel H Opie
Lancet (London, England)|August 1, 2006
Donepezil for severe Alzheimer's diseaseLionel H Opie
Circulation|January 24, 2007
Metabolic syndromeLionel H Opie
The New England Journal of Medicine|August 16, 2013
Mediterranean diet for primary prevention of cardiovascular diseaseLionel H Opie
Lancet (London, England)|August 27, 2013
Recording of smoking history in death notificationLionel H Opie
Journal of the American College of Cardiology|March 7, 2009
Caloric restriction models reverse metabolic syndromeLionel H Opie
Cardiovascular Journal of Africa|September 6, 2014
Cognitive decline: mechanisms and proposed role of the renin-angiotensin-aldosterone systemLionel H Opie
Journal of the American College of Cardiology|December 3, 2014
Early intravenous beta-blockade before primary percutaneous coronary intervention gives major benefits, apparently without side effectsLionel H Opie
Experimental Physiology|July 27, 2012
Cardioprotection at a distance - remote conditioning takes the stageLionel H Opie
Pageof 13